Tract Bio

Tract Bio is a pioneering biotechnology research company dedicated to transforming the treatment of cancer and inflammatory diseases. Based in Charlotte, North Carolina, Tract Bio’s innovative stem cell discovery platform, stemECHO™, is revolutionizing the way therapies are developed. This groundbreaking platform enables the reliable generation of pure stem cell libraries, preserving their functional and genetic integrity, and has already yielded promising avenues for treatments targeting a range of conditions, including esophageal adenocarcinoma, lung cancer, and Crohn’s Disease. Tract Bio is currently advancing TP-101, a novel drug combination identified through the stemECHO™ platform, showcasing the company's commitment to developing targeted therapies. With a growing team and unwavering dedication to innovation, Tract Bio is poised to make a significant impact on the future of healthcare. Located in Charlotte, North Carolina, Tract Bio is leading the charge in biotechnology research. We invite you to connect with our management team to create a customized and exclusive company showcase and product listing on our platform.